About Metaphore
Metaphore is a Healthcare company based in Cambridge (United States) founded in 2021 by Lovisa Afzelius and Daniel Acker. Metaphore has raised $50 million across 3 funding rounds from investors including Flagship Pioneering, TOHO HOLDINGS and Lotte Holdings. Its chief executive, as recorded, is Lovisa Afzelius. Metaphore offers products and services including MIMIC Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Asimov, Cellarity and Evolved By Nature; 3 of its 3 listed competitors have raised funding.
Company details
Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.
- Headquarters Cambridge, United States
- Founders Lovisa Afzelius, Daniel Acker
- SectorsHealthcare
- Email••••••••
- Website metaphorebio.com
- Social LinkedIn X
- Total Equity Funding$50M (USD)
in 3 rounds
- InvestorsFlagship Pioneering
& 2 more
Products & Services of Metaphore
Metaphore offers a comprehensive portfolio of products and services, including MIMIC Platform.
Uses machine learning and molecular mimicry for therapeutic insights and drug development.
Funding Insights of Metaphore
Metaphore has successfully raised a total of $50M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50M
- Total Rounds 3
- First Round $50M
(May 2023)
- Investors Count 3
All 3 funding rounds of Metaphore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2026 | Series C | – | – | ||
| Apr 2026 | Series C | – | – | ||
| May 2023 | $50M | Series C | – | – |
3 investors in total: 3 institutional.
Investors in Metaphore
Metaphore has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Flagship Pioneering, TOHO HOLDINGS and Lotte Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences-focused venture capital firm | 1999 | flagshippioneering.com | Cambridge, United States | |
| tohohd.co.jp | ||||
| lotte-hd.com |
Investor details for Metaphore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Metaphore
18 people are tracked at Metaphore (7 in leadership, 11 in team).
| Name | Role | Group |
|---|---|---|
Lovisa Afzelius | Co-Founder & CEO | Leadership |
Daniel Acker | Co-Founder & CIO | Leadership |
Peter Rogov | Associate Director, NGS And Molecular Biology | Leadership |
Chaz Hinzman | Head Of Strategy And Operations | Leadership |
Marcin Paduch | Vice President, Head Of Platform Biology | Leadership |
Susana Gordo | Senior Director Of Translational Science | Leadership |
Jake Siegel | Director, Computational Biology And Data Science | Leadership |
Katherine Norwood | Scientist II | Team |
Derek Vandyke | Senior Scientist II | Team |
Ben Goldberg | Scientist Ii, Discovery Sciences And Technology | Team |
Abdul Bais Kadli | Scientist | Team |
Kayce Vanpelt | Lab Operations Senior Associate | Team |
Bharat Madan | Senior Scientist II | Team |
Robert W. Link | Scientist Ii, Computational Biology | Team |
Tatiana Athanasopoulos | Senior Research Associate | Team |
Alexandre Fassio | Senior Scientist Ii, Computational Antibody Design | Team |
Daniel Monaco | Senior Data Scientist | Team |
Evan Latowsky | Research Associate II | Team |
Complete people profiles for Metaphore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Metaphore
3 dated milestones of Metaphore across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Metaphore is founded.
- Funding First funding round of $50.0M.
- Funding Latest funding round, Series C,.
Competitors of Metaphore
Metaphore has 3 listed competitors in our database, 3 of them funded. They include Asimov, Cellarity and Evolved By Nature.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| cellarity.com | 2015 | Cambridge, United States | $294M | 117 | Developer of drugs to treat various diseases | |
| evolvedbynature.com | 2013 | Medford, United States | $190M | 99 | Digital technology for biomedicinal molecule development in research is utilized. |
Detailed competitors of Metaphore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Metaphore
The website of Metaphore (metaphorebio.com) receives about 4K visits a month.
- Monthly visits4K
▲ 5.3% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Metaphore (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Metaphore
Complete news archive for Metaphore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metaphore
Metaphore was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Metaphore is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Lovisa Afzelius is the CEO of Metaphore, as recorded in our data. They have also founded this company.
Metaphore is a funded company, having raised a total of $50M across 3 funding rounds to date. The company's 1st funding round was a Series C of $50M, raised on May 2023.
Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.
Metaphore's top competitors include Asimov, Cellarity and Evolved By Nature.
Metaphore offers MIMIC Platform.
Metaphore has 3 investors. Key investors include Flagship Pioneering, TOHO HOLDINGS, and Lotte Holdings.